Literature DB >> 2512341

The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway.

E Arteaga1, P Valenzuelaa, A Cattani, M del Valle.   

Abstract

To investigate whether or not a cholinergic pathway is involved in the paradoxical response of GH to TRH in constitutionally tall children, we studied 8 healthy prepubertal children aged 4 2/12-7 10/12 yr, whose heights were over the 95th percentile of the NCHS tables. We defined as "paradoxical" a GH increment greater than 5 ng/ml in response to TRH. Five out of 8 children showed a paradoxical response of GH to TRH (mean GH peak after TRH of 10.7 +/- 1.1 ng/ml). Pretreatment with atropine (0.01 mg/kg IM 30 min prior to the TRH administration) abolished the TRH induced GH rise (peak GH after TRH of 1.5 +/- 1.0 ng/ml, p less than 0.01) but did not modify the TSH response (peak TSH after TRH: basal conditions 8.7 +/- 0.8 microU/ml, post atropine: 9.5 +/- 1.4 microU/ml, p greater than 0.05). Our results demonstrate that a cholinergic pathway is involved in the paradoxical response of GH to TRH in constitutionally tall children.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512341     DOI: 10.1007/BF03350756

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Cholinergic muscarinic blockade produces short-term suppression of growth hormone secretion in children with tall stature.

Authors:  P C Hindmarsh; P J Pringle; C G Brook
Journal:  Clin Endocrinol (Oxf)       Date:  1988-09       Impact factor: 3.478

2.  Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29.

Authors:  V Jordan; C Dieguez; I Lafaffian; M D Rodriguez-Arnao; A Gomez-Pan; R Hall; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1986-03       Impact factor: 3.478

3.  Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man.

Authors:  M S Anderson; C Y Bowers; A J Kastin; D S Schalch; A V Schally; P J Snyder; R D Utiger; J F Wilber; A J Wise
Journal:  N Engl J Med       Date:  1971-12-02       Impact factor: 91.245

4.  Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist.

Authors:  F Massara; E Ghigo; S Goffi; G M Molinatti; E E Müller; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1984-11       Impact factor: 5.958

5.  Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

Authors:  K Maeda; Y Kato; N Yamaguchi; K Chihara; S Ohgo
Journal:  Acta Endocrinol (Copenh)       Date:  1976-01

6.  Endogenous cholinergic modulation of growth-hormone secretion in normal and acromegalic humans.

Authors:  S A Leveston; P E Cryer
Journal:  Metabolism       Date:  1980-08       Impact factor: 8.694

7.  Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism.

Authors:  R Collu; G Leboeuf; J Letarte; J R Ducharme
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

8.  Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading tests in tall children and adolescents.

Authors:  D Evain-Brion; P Garnier; R M Schimpff; J L Chaussain; J C Job
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

9.  Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man.

Authors:  A Peñalva; L Villanueva; F Casanueva; F Cavagnini; A Gomez-Pan; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.

Authors:  G Delitala; T Frulio; A Pacifico; M Maioli
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.